Cell cycle effects and cellular pharmacology of 5-aza-2'-deoxycytidine - PubMed (original) (raw)
- PMID: 6207950
- DOI: 10.1007/BF00269027
Cell cycle effects and cellular pharmacology of 5-aza-2'-deoxycytidine
R L Momparler et al. Cancer Chemother Pharmacol. 1984.
Abstract
The cytotoxic action of 5-aza-2'-deoxycytidine (5-AZA-CdR) in synchronized cells and logarithmic- and plateau-phase cultures of EMT6 murine tumor cells was investigated. 5-AZA-CdR produced a greater cell kill of S phase cells than of cells in G1 phase. Cells in the logarithmic phase of growth were more sensitive to the cytotoxic effects of 5-AZA-CdR than cells in the plateau phase of growth. These results indicate that 5-AZA-CdR produces a preferential kill of cells in the S phase of the cell cycle. 5-AZA-CdR did not block the cell cycle progression of cells into S phase. The survival curve of EMT6 cells exposed to 5-AZA-CdR suggests that the cytotoxic action of this analogue is not self-limiting. The mutagenic activity of 5-AZA-CdR was investigated using induction of 6-thioguanine resistance in Chinese hamster ovary cells. 5-AZA-CdR was not a detectable mutagen in this assay system.
References
- Cancer Res. 1977 Oct;37(10):3684-9 - PubMed
- Cell. 1980 May;20(1):85-93 - PubMed
- Cancer Res. 1972 Dec;32(12):2720-5 - PubMed
- Neoplasma. 1971;18(5):493-503 - PubMed
- Biochem Pharmacol. 1979 Apr 15;28(8):1443-4 - PubMed